上海医药

- 601607

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
上海医药(601607) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入26,029,508.8919,750,831.4213,259,215.736,622,646.1523,198,129.98
营业收入26,029,508.8919,750,831.4213,259,215.736,622,646.1523,198,129.98
二、营业总成本25,300,886.3719,137,981.3512,820,580.756,403,366.5622,490,725.09
营业成本22,896,694.7017,354,589.9011,553,349.215,759,161.3720,149,492.31
营业税金及附加73,810.6454,835.7737,717.2919,273.6371,627.37
销售费用1,390,219.151,047,004.88773,287.55391,147.131,427,897.49
管理费用571,182.74419,311.77276,273.74137,897.69499,168.92
财务费用148,575.76115,434.7677,321.9741,817.70131,319.25
研发费用220,403.37146,804.27102,630.9954,069.05211,219.76
资产减值损失----------
公允价值变动收益40,473.1423,902.3519,684.248,940.2021,873.79
投资收益-6,812.27-8,382.44-19,899.2415,516.4853,311.71
其中:对联营企业和合营企业的投资收益12,932.878,991.90-6,541.9320,168.4352,674.33
汇兑收益----------
三、营业利润766,723.47655,595.51455,808.42249,059.40901,465.04
加:营业外收入4,068.972,750.801,810.561,394.923,277.81
减:营业外支出65,362.776,446.804,239.731,264.6723,907.52
其中:非流动资产处置损失----------
四、利润总额705,429.67651,899.52453,379.25249,189.66880,835.33
减:所得税费用188,772.65156,522.70111,679.1553,885.09181,633.85
五、净利润516,657.03495,376.82341,700.10195,304.57699,201.48
归属于母公司所有者的净利润376,799.96379,677.07260,982.18151,764.93561,715.20
少数股东损益139,857.07115,699.7680,717.9243,539.64137,486.28
六、每股收益
基本每股收益(元/股)1.02001.03000.71000.41001.6100
稀释每股收益(元/股)1.02001.03000.71000.41001.6100
七、其他综合收益-12,671.99-17,096.64-12,284.93-3,135.33-22,648.03
八、综合收益总额503,985.04478,280.18329,415.18192,169.24676,553.45
归属于母公司所有者的综合收益总额364,323.38362,933.53248,290.46148,709.33539,022.25
归属于少数股东的综合收益总额139,661.66115,346.6581,124.7243,459.91137,531.19
下载全部历史数据到excel中 返回页顶